Mats Dahlberg

Mats Dahlberg is responsible for the business area Transactions and focuses on capital-markets, M&A and alternative investments. Mats Dahlberg has been involved in a large number of capital market transactions such as IPOs, public take-overs, rights issues, accelerated book buildings, private placements, spin-offs, MTN programs and incentive programs.

• Advisor to Momentum Group AB in connection with recommended public offer to the shareholders of Swedol AB
• IPO by Momentum Group on Nasdaq Stockholm (spin-off from B&B Tools)
• IPO by AddLife on Nasdaq Stockholm (spin-off from Addtech)
• Rights issue in NIBE of approximately SEK 3 billion
• Advisor to Cherry in connection with public takeover bid
• IPO by Immunicum on Nasdaq Stockholm and several public capital raisings

• Capital markets: Debt
• Capital markets: Equity
• M&A
• Private equity
• Private equity funds

• Consumer goods and services
• Healthcare
• Industrials
• Pharma and life sciences
• Tech and telecoms

• Swedish Bar Association

• Officer, IBA M&A Committee

• LL.M., Stockholm University 1999
• Bachelor of Science in Business Administration and Economics, Stockholm University 1999